BioCure has developed or is currently developing a pipeline of innovative products in the medical device and biotechnology sectors including:

• a microsphere embolic agent, licensed to Biocompatibles UK Ltd. and marketed under the trademark BeadBlock.
• a spine product being developed in collaboration with a global leader in the spine and orthopedic market.
• a sprayable wound dressing in collaboration with the Center for Military Biomaterials Research ( http://128.6.231.79/cmbr/index.htm); a 501(k) is planned for submission by December 2007. It is available for commercial partnering.
• a liquid embolic agent, LiquiGel ™ Embolic Agent, an effective, easy-to-use, non-toxic liquid embolic agent providing a clog-free targeted embolization for a range of embolization indications*. This development is current available for partnering.
• an embolic coil, GelCoil ™. This development is current available for partnering.
• a novel co-axial nitinol microcatheter with unique applications for delivery access. This development is is current available for partnering.